Results 281 to 290 of about 93,886 (309)

Oral splicing modulator branaplam in Huntington's disease: a phase 2 randomized controlled trial. [PDF]

Nat Med
Borowsky B, Ramos H, Caputo A, Hartmann A, Faller T, Peters T, Sui Y, Liu F, Meadowcroft M, David OJ, Laisney M, Kinhikar A, Marder KS, Tabrizi SJ, Landwehrmeyer GB, Leavitt BR.   +15 more
europepmc   +1 more source

Exploring the principles of logotherapy in genetic counseling: Enhancing decision‐making, adaptation, and justice

Journal of Genetic Counseling, Volume 35, Issue 1, February 2026.
Abstract Logotherapy is a psychological approach originated by Viktor Frankl, shaped by the thesis that meaning can be discovered even in the most tragic of human circumstances, and through a human's will‐to‐meaning, that individuals have both freedom and responsibility to discover meanings in the moment and ultimate meanings from their unique ...
Nour Chanouha, Anna Chassevent, Ellen F. Macnamara, Kendra Schaa, Renata Thoeny, Janeta Tansey   +5 more
wiley   +1 more source

Insulin-like growth factor 2 reduces Huntington's disease aggregates via AKT and NF-κB signaling in huntington's disease. [PDF]

Cell Biosci
Tung YS, Tung CW, Chan SC, Chen YC, Wu PM, Cheng PH, Chen CM, Yang SH.   +7 more
europepmc   +1 more source

The Sense of Smell (SoS) Atlas: Its Creation and First Application to Investigate COVID‐19 Related Anosmia With a Comprehensive Quantitative MRI Protocol

Journal of Magnetic Resonance Imaging, Volume 63, Issue 2, Page 574-593, February 2026.
ABSTRACT Background The loss of smell (anosmia) has been noted in numerous diseases, including COVID‐19. Inflammatory and microstructural alterations are possible underlying mechanisms of anosmia in COVID‐19. However, no atlas exists to study olfaction and the associated tissue property changes.
Marta Gaviraghi, Eleonora Lupi, Elena Grosso, Andrea Fusari, Mattia Baiguera, Anita Monteverdi, Marco Battiston, Francesco Grussu, Baris Kanber, Ferran Prados Carrasco, Rebecca S. Samson, Janine Makaronidis, Marios C. Yiannakas, Michael S. Zandi, Rachel L. Batterham, Egidio D'Angelo, Fulvia Palesi, Claudia A. M. Gandini Wheeler‐Kingshott   +17 more
wiley   +1 more source

Revolutionizing Huntington's Disease Treatment: Breakthroughs in AAV-Mediated Gene Therapy. [PDF]

Cells
Gavgani PM, García-Domínguez M.
europepmc   +1 more source

Neuro‐Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets

MedComm, Volume 7, Issue 2, February 2026.
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo, Hui Liu, Yu‐Jing Song, Jian‐Hua Wang, Danfeng Liu, Zhi‐Wei Zheng, Jia‐Jun Li, Boya Li, An Song, Wei He, Lei‐Lei Yang, Shuo Wang   +11 more
wiley   +1 more source

Regulation of Genome Architecture in Huntington's Disease. [PDF]

Biochemistry
Portillo-Ledesma S, Hang M, Schlick T.
europepmc   +1 more source

Rally‐Round‐the‐Flag: The Case of COVID‐19 in Denmark

Scandinavian Political Studies, Volume 49, Issue 1, February 2026.
ABSTRACT Rally‐round‐the‐flag describes a situation where voters rally behind their government and leader in the fight against an external enemy. The COVID‐19 pandemic was such an external enemy and Danish voters responded immediately with an increased support of about seven percentage points for the government and a significant 33 percentage points ...
Kasper M. Hansen
wiley   +1 more source